Diabetic Peripheral Neuropathy.

No abstract is available for this paper.

• Publication year

  2022

• Venue

  Handbook of Experimental Pharmacology

• Publication date

  2022-05-24

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/164_2022_585PMID 35606621
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Incidence, hospitalization and mortality and their changes over time in people with a first ever diabetic foot ulcer

  2021cited by this paper
• Axonal swellings are related to type 2 diabetes, but not to distal diabetic sensorimotor polyneuropathy

  2021cited by this paper
• Corneal confocal microscopy identifies small fibre damage and progression of diabetic neuropathy

  2021cited by this paper
• Keratinocyte Biomarkers Distinguish Painful Diabetic Peripheral Neuropathy Patients and Correlate With Topical Lidocaine Responsiveness

  2021cited by this paper
• Progression and regression of nerve fibre pathology and dysfunction early in diabetes over 5 years.

  2021cited by this paper
• The current burden of diabetic foot disease.

  2021cited by this paper
• Twenty years with diabetes and amputations: a retrospective population‐based cohort study

  2020cited by this paper
• A systematic review of multidisciplinary teams to reduce major amputations for patients with diabetic foot ulcers.

  2020cited by this paper
• Diabetic Peripheral Neuropathy: Diagnosis and Treatment.

  2020cited by this paper
• Oral versus Intravenous Antibiotics for Bone and Joint Infection

  2019cited by this paper
• Diabetic neuropathy

  2019cited by this paper
• Oral antibiotic therapy in diabetic foot osteomyelitis: one small step or a giant leap of faith?

  2019cited by this paper
• Structural and Functional Abnormalities of the Primary Somatosensory Cortex in Diabetic Peripheral Neuropathy: A Multimodal MRI Study

  2019cited by this paper
• Oral versus intravenous antibiotics for bone and joint infections: the OVIVA non-inferiority RCT.

  2019cited by this paper
• Multicentre, double-blind, crossover trial to identify the Optimal Pathway for TreatIng neurOpathic paiN in Diabetes Mellitus (OPTION-DM): study protocol for a randomised controlled trial

  2018cited by this paper
• Oxcarbazepine for neuropathic pain.

  2017cited by this paper
• Rare NaV1.7 variants associated with painful diabetic peripheral neuropathy

  2017cited by this paper
• Diabetic Foot Ulcers and Their Recurrence.

  2017cited by this paper
• Stratifying patients with peripheral neuropathic pain based on sensory profiles: algorithm and sample size recommendations

  2017cited by this paper
• Inflammation as a Therapeutic Target for Diabetic Neuropathies

  2016cited by this paper
• Diabetic Neuropathy: A Position Statement by the American Diabetes Association

  2016cited by this paper
• Oxycodone for neuropathic pain in adults.

  2016cited by this paper
• In vivo corneal confocal microscopy in diabetes: Where we are and where we can get.

  2016cited by this paper
• A systematic review and individual patient data meta-analysis of prognostic factors for foot ulceration in people with diabetes: the international research collaboration for the prediction of diabetic foot ulcerations (PODUS).

  2015cited by this paper
• Treatment of painful diabetic neuropathy

  2015cited by this paper
• Diabetic neuropathic pain: Physiopathology and treatment.

  2015cited by this paper
• Efficacy and safety of pregabalin for treating painful diabetic peripheral neuropathy: a meta‐analysis

  2015cited by this paper
• Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis.

  2015cited by this paper
• Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia.

  2014cited by this paper
• Persistent mechanical allodynia positively correlates with an increase in activated microglia and increased P‐p38 mitogen‐activated protein kinase activation in streptozotocin‐induced diabetic rats

  2014cited by this paper
• Why are there no good treatments for diabetic neuropathy?

  2014cited by this paper
• Does the Prevailing Hypothesis That Small-Fiber Dysfunction Precedes Large-Fiber Dysfunction Apply to Type 1 Diabetic Patients?

  2014cited by this paper
• Pathogenesis of Painful Diabetic Neuropathy

  2014cited by this paper
• Pharmacologic Interventions for Painful Diabetic Neuropathy

  2014cited by this paper
• The effect of oxcarbazepine in peripheral neuropathic pain depends on pain phenotype: A randomised, double‐blind, placebo‐controlled phenotype‐stratified study

  2014cited by this paper
• Duloxetine and pregabalin: High‐dose monotherapy or their combination? The “COMBO‐DN study” – a multinational, randomized, double‐blind, parallel‐group study in patients with diabetic peripheral neuropathic pain

  2013cited by this paper
• Association of Subclinical Inflammation With Polyneuropathy in the Older Population

  2013cited by this paper
• Management of Painful Diabetic Neuropathy: Guideline Guidance or Jungle?

  2012cited by this paper
• Randomized, Placebo-Controlled Comparison of Amitriptyline, Duloxetine, and Pregabalin in Patients With Chronic Diabetic Peripheral Neuropathic Pain

  2012cited by this paper
• A systematic review and meta-analysis of α-lipoic acid in the treatment of diabetic peripheral neuropathy.

  2012cited by this paper
• Frequency-modulated electromagnetic neural stimulation (FREMS) as a treatment for symptomatic diabetic neuropathy: results from a double-blind, randomised, multicentre, long-term, placebo-controlled clinical trial

  2012cited by this paper
• A Comparative Evaluation of Amitriptyline and Duloxetine in Painful Diabetic Neuropathy

  2011cited by this paper
• Evidence-based guideline: Treatment of painful diabetic neuropathy: Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation

  2011cited by this paper
• Diabetic Foot Ulcers and Vascular Insufficiency: Our Population Has Changed, but Our Methods Have Not

  2011cited by this paper
• Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management

  2011cited by this paper
• Diabetic distal symmetric polyneuropathy: Effect of low-intensity laser therapy

  2011cited by this paper
• Diabetic neuropathy: cellular mechanisms as therapeutic targets

  2011cited by this paper
• Pharmacological Treatment of Diabetic Neuropathic Pain

  2011cited by this paper
• Intraepidermal nerve fiber density at the distal leg: a worldwide normative reference study

  2010cited by this paper
• Treating diabetic peripheral neuropathic pain.

  2010cited by this paper
• Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial

  2010cited by this paper
• Role of Low‐Level Laser Therapy in Neurorehabilitation

  2010cited by this paper
• Oxidative stress and diabetic complications.

  2010cited by this paper
• Pulsed electromagnetic fields to reduce diabetic neuropathic pain and stimulate neuronal repair: a randomized controlled trial.

  2009cited by this paper
• Neuropathic pain is associated with increased nodal persistent Na+ currents in human diabetic neuropathy

  2009cited by this paper
• Microvascular reactivity and inflammatory cytokines in painful and painless peripheral diabetic neuropathy.

  2009cited by this paper
• A benfotiamine-vitamin B combination in treatment of diabetic polyneuropathy.

  2009cited by this paper
• Activity-dependent excitability changes suggest Na+/K+ pump dysfunction in diabetic neuropathy.

  2008cited by this paper
• Opioid complications and side effects.

  2008cited by this paper
• Sensory loss, pains, motor deficit and axonal regeneration in length-dependent diabetic polyneuropathy

  2008cited by this paper
• Utilization of Nerve Conduction Studies for the Diagnosis of Polyneuropathy in Patients with Diabetes: A Retrospective Analysis of a Large Patient Series

  2008cited by this paper
• Serum Heat Shock Protein 27 and Diabetes Complications in the EURODIAB Prospective Complications Study

  2008cited by this paper
• Does Anodyne Light Therapy Improve Peripheral Neuropathy in Diabetes?

  2008cited by this paper
• Risk Factors Related to Inflammation and Endothelial Dysfunction in the DCCT/EDIC Cohort and Their Relationship With Nephropathy and Macrovascular Complications

  2008cited by this paper
• Aldose reductase inhibitors for the treatment of diabetic polyneuropathy.

  2007cited by this paper
• Skin biopsy as a diagnostic tool in peripheral neuropathy

  2007cited by this paper
• Clinical use of pregabalin in the management of central neuropathic pain

  2007cited by this paper
• Antidepressants for neuropathic pain.

  2007cited by this paper
• Long-Term Clinical Effects of Epalrestat, an Aldose Reductase Inhibitor, on Diabetic Peripheral Neuropathy

  2006cited by this paper
• Advanced glycation end products: sparking the development of diabetic vascular injury.

  2006cited by this paper
• Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo‐controlled study

  2005cited by this paper
• Kv4 potassium channel subunits control action potential repolarization and frequency‐dependent broadening in rat hippocampal CA1 pyramidal neurones

  2005cited by this paper
• The global burden of diabetic foot disease.

  2005cited by this paper
• Management of Diabetic Peripheral Neuropathy

  2005cited by this paper
• Diabetic neuropathies: a statement by the American Diabetes Association.

  2005cited by this paper
• Early Painful Diabetic Neuropathy Is Associated with Differential Changes in Tetrodotoxin-sensitive and -resistant Sodium Channels in Dorsal Root Ganglion Neurons in the Rat*

  2004cited by this paper
• Diabetic somatic neuropathies.

  2004cited by this paper
• Restoration of sensation, reduced pain, and improved balance in subjects with diabetic peripheral neuropathy: a double-blind, randomized, placebo-controlled study with monochromatic near-infrared treatment.

  2004cited by this paper
• Pathophysiology of neuropathic pain.

  2004cited by this paper
• Low-intensity laser therapy for painful symptoms of diabetic sensorimotor polyneuropathy: a controlled trial.

  2004cited by this paper
• Sodium valproate for painful diabetic neuropathy: a randomized double-blind placebo-controlled study.

  2004cited by this paper
• Neuropathic Pain Questionnaire—Short Form

  2003cited by this paper
• Corneal confocal microscopy: a non-invasive surrogate of nerve fibre damage and repair in diabetic patients

  2003cited by this paper
• Static magnetic field therapy for symptomatic diabetic neuropathy: a randomized, double-blind, placebo-controlled trial.

  2003cited by this paper
• Evidence Base for Diabetes Care

  2002cited by this paper
• Molecular understanding of hyperglycemia's adverse effects for diabetic complications.

  2002cited by this paper
• Polyol pathway and diabetic peripheral neuropathy.

  2002cited by this paper
• Hypersensitivity of spinothalamic tract neurons associated with diabetic neuropathic pain in rats.

  2002cited by this paper
• Inflammation and Atherosclerosis

  2002cited by this paper
• Percutaneous electrical nerve stimulation: a novel analgesic therapy for diabetic neuropathic pain.

  2000cited by this paper
• Upregulation of a silent sodium channel after peripheral, but not central, nerve injury in DRG neurons.

  1999cited by this paper
• Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.

  1999cited by this paper
• The bradykinin-induced release of substance P from nerve fibre endings in the rat saphenous nerve neuroma is not related to electrophysiological excitation.

  1988cited by this paper

• Genetic polymorphisms in DNA repair gene XRCC1 and the risk of diabetic polyneuropathy

  2026cites this paper
• Raster Scan optoacoustic Mesoscopy for detecting microvascular complications in diabetes mellitus: A narrative brief review.

  2025cites this paper
• Blood pressure variability is associated with the occurrence of diabetic microangiopathy in type 2 diabetes mellitus: a cross-sectional study

  2025cites this paper
• Pandanus tectorius fruits attenuated cell injury and oxidative stress in high glucose-induced Schwann cells by activating Nrf2/Keap1 signaling pathway

  2025cites this paper
• Investigating the Mechanism by Which RMRP Regulates Diabetic Peripheral Neuropathy via the miR‐3142

  2025cites this paper
• What Footwear Do People with Diabetes Mellitus Use? A Narrative Review

  2025cites this paper
• Targeted neural stem cell-derived extracellular vesicles loaded with Sinomenine alleviate diabetic peripheral neuropathy via WNT5a/TRPV1 pathway modulation

  2025cites this paper
• Peripheral neuropathies induced by BRAF+MEK inhibitor combinations: a real-world study based on FAERS database 2011-2022.

  2025cites this paper
• Early diagnosis and risk factors of diabetic peripheral neuropathy in type 1 diabetes: insights from current perception threshold testing

  2025cites this paper
• Quantitative study and related factors analysis of sciatic neuropathy in type 2 diabetes mellitus patients by elastic imaging virtual tissue imaging quantification technique

  2025cites this paper
• Mechanism and Application of Chinese Herb Medicine in Treatment of Peripheral Nerve Injury

  2024cites this paper
• Diabetic peripheral neuropathy and neuromodulation techniques: a systematic review of progress and prospects

  2024cites this paper
• Delayed treatment of diabetic foot ulcer in patients with type 2 diabetes and its prediction model

  2024cites this paper
• Validation of the Histamine‐ and Heat‐Induced Axon‐Reflex Flare Response in a Nonselected Population of People With Type 1 Diabetes

  2024cites this paper
• siRNA a promising tool for diabetes complications

  2023cites this paper
• Construction and clinical validation of a nomogram-based predictive model for diabetic retinopathy in type 2 diabetes.

  2023cites this paper
• Painful Diabetic Neuropathy: The Need for New Approaches

  2022cites this paper
• Nonoperative Treatment of Charcot Neuro-osteoarthropathy.

  2022cites this paper
• Foot deformities in patients with diabetic mellitus (with and without peripheral neuropathy).

  2021cites this paper
• Identification of Key Biomarkers and Immune Infiltration in Sciatic Nerve of Diabetic Neuropathy BKS-db/db Mice by Bioinformatics Analysis

  2021cites this paper
• Effectiveness of acupuncture for treatment of diabetic peripheral neuropathy

  2019cites this paper
• Biological effects of amniotic membrane on diabetic foot wounds: a systematic review.

  2018cites this paper
• Pie diabético. Abordaje multidisciplinar

  2015cites this paper